Eidos Therapeutics, Inc.: 15-12B filed Feb 5, 2021

Form type

15-12B

Filing date

Feb 5, 2021

Accession number

0001193125-21-030646

Filer

Eidos Therapeutics, Inc. (CIK 1731831)